CRISPR Therapeutics CRSP Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's income tax?
- CRISPR Therapeutics (CRSP) reported income tax of $839K in Q1 2026.
- How has CRISPR Therapeutics's income tax changed year-over-year?
- CRISPR Therapeutics's income tax decreased by 24.3% year-over-year, from $1.11M to $839K.
- What is the long-term trend for CRISPR Therapeutics's income tax?
- Over 3 years (2022 to 2025), CRISPR Therapeutics's income tax has grown at a 123.6% compound annual growth rate (CAGR), from -$325K to $3.63M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.